Purchase Order 75N95023P00385
Award Date 6/27/23
Potential Completion Date 6/26/24
Potential Value $200K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Mayagüez, Puerto Rico
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- CDI Laboratories Inc., doing business as CDI Laboratories, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide 12 samples of its HUPROT V4.0 Human Proteome Microarray and HUSCAN (PHIP-SEQ) assay service. The contract calls for CDI Laboratories to deliver its proteomics platform and associated sequencing capabilities to support research efforts at the NIH aimed at better understanding...
- This is a $98,253.09 firm-fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the U.S. Department of Veterans Affairs (VA) to CDI Laboratories Inc., a small disadvantaged business manufacturer. The contract is for the provision of CDI's HuProt v4.0 Human Proteome Microarray, containing over 21,000 human proteins, as well as its VirScan viral antibody profiling and immuneprofiler antibody analysis services. This work supports biomedical research efforts,...
- This firm-fixed-price purchase order contract was awarded to CDI Laboratories Inc., a small disadvantaged business, to provide its proprietary HUPROT V4.0 ARRAY protein microarray product and related antibody profiling and analysis services to the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH). The $121,379.50 contract supports biomedical research efforts, particularly in the areas of infectious diseases, heart/lung disorders, aging, and...
- This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to CDI Laboratories Inc. for $96,812.10. The contract is for the provision of 110 samples and bioinformatics analysis of serum samples using CDI's proprietary HuProt v4.0 protein arrays to support COVID-19 research. CDI Laboratories is a small disadvantaged business that has received numerous prime federal contracts from NIH...
- This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to CDI Laboratories Inc., a self-certified small disadvantaged business and manufacturer of goods. The contract, valued at $23,999.72, is for CDI Laboratories to provide its proprietary human proteome microarray assay services to support biomedical research efforts, particularly in the areas of infectious...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Aging to CDI Laboratories Inc. for immuneprofiler analysis of 30 serum samples using CDI's HuProt microarrays. The purpose is to directly compare the sample data obtained from phage immunoprecipitation sequencing (PhIP-Seq). The contract has a period of performance from April 26, 2021 to April 25, 2022 and a potential value of $218,400.00. The award...
- CD Biosciences Inc., doing business as Creative Biomart, Creative Biolabs, CD Genomics, and Profacgen Division, has been awarded a $15,000 firm fixed price purchase order by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to provide creative diagnostics glycoproteins and nucleoproteins. The contract has a period of performance from September 22, 2023 through December 29, 2023, with all work to be conducted by the prime contractor in East Yaphank, New...
- The National Institutes of Health's National Institute on Drug Abuse awarded a $72,187.43 firm fixed price purchase order to Agilent Technologies Inc. for the production and delivery of seven oligonucleotide libraries. Per the original solicitation notice, each library will contain 244,000 unique deoxyribonucleic acid oligonucleotides that are 230 nucleotides in length. The libraries are intended for use in deep antibody profiling for the National Institute of Mental Health's Translational...
- This $246,997.36 firm-fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Agilent Technologies Inc. for the procurement of DNA probe labeling and microarray kits. The award is the result of a sole-source procurement conducted under FAR 13.106-1, as NIAID determined Agilent to be the only responsible source capable of meeting the agency's specific requirements for these specialized laboratory consumables needed to support gene...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $126,095.20 firm fixed price purchase order to Agilent Technologies Inc. Customer Service And Sales Division. Under the terms of the contract, Agilent will provide 17 single lot-matched fluorescent DNA probe labeling kits, 100 lot-matched cDNA expression microarrays, gene expression hybridization and wash pack kits, and shipping and handling services in...